What is Vir Biotechnology, Inc.'s net investment in lease?

Vir Biotechnology, Inc. (VIR) reported net investment in lease of $60.76M in Q1 2026.

How has Vir Biotechnology, Inc.'s net investment in lease changed year-over-year?

Vir Biotechnology, Inc.'s net investment in lease increased by 3.8% year-over-year, from $58.56M to $60.76M.

What is the long-term trend for Vir Biotechnology, Inc.'s net investment in lease?

Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s net investment in lease has grown at a 0.0% compound annual growth rate (CAGR), from $61.95M to $62.1M.

Vir Biotechnology, Inc. VIR Net Investment in Lease

Net Investment in Lease at other companies

Viridian Therapeutics, Inc.VRDN

——

Iovance Biotherapeutics, Inc.IOVA

——

Nuvation BioNUVB

——

Enliven TherapeuticsELVN

——

ImmunityBio, Inc.IBRX

——

BiohavenBHVN

——

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.71B+61.1%

Enterprise value$1.53B+102%

P/S26.2×-24.8×

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s net investment in lease?: Vir Biotechnology, Inc. (VIR) reported net investment in lease of $60.76M in Q1 2026.
How has Vir Biotechnology, Inc.'s net investment in lease changed year-over-year?: Vir Biotechnology, Inc.'s net investment in lease increased by 3.8% year-over-year, from $58.56M to $60.76M.
What is the long-term trend for Vir Biotechnology, Inc.'s net investment in lease?: Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s net investment in lease has grown at a 0.0% compound annual growth rate (CAGR), from $61.95M to $62.1M.